Pharmaspectra

About 

Medical data leader Pharmaspectra grew substantially under Inflexion’s ownership, including a new digital platform and entry into China before its sale to a NYSE-listed trade buyer. 

Pharmaspectra is a global provider of medical affairs data to the pharmaceutical and biotech industry and hosts the world’s largest, continuously updated and integrated online repository of disseminated medical science information. This includes 16 million meeting presentations, 28 million publication abstracts and 417,000 clinical trials results. This data is used across the pharmaceutical sector where Pharmaspectra has an expansive and diverse customer base including 13 of the top 20 pharma companies. The firm has offices in the UK, US, and India. 

Value acceleration 

Inflexion used its extensive experience in scaling and professionalising companies to support Pharmaspectra, with the digital team supporting the creation of a new medical affairs data and insights platform and substantial investment into its sales team, marketing and client services. Inflexion also supported the international expansion of the business including the build-out of the team in India and developing Pharmaspectra’s entry strategy into China.